President of Linshom Management LLC
Mr. Feldman is a founding member of Linshom and an integral part of the technical team. Mr. Feldman is the founder and president of Artep Incorporated (www.artepinc.com) Artep, Incorporated is a high technology small business with a broad range of engineering experience in supporting experimental groups at universities, large scale research institutions and the military. For over 30 years Artep has produced high precision instruments for space and laboratory research. Mr. Feldman has been the senior software engineer on numerous space-based payloads and laboratory instruments.
Chief Executive Officer
Mr. Richard Hughen is a high impact executive leader, business builder with start-up, small-cap, and fortune 100 experience, innovative thinker and creative problem solver with expertise in building shareholder value, milestone achievement with unrelenting focus, leading complex, cross-functional teams, marketing strategy and business development, product development and commercialization, trial, regulatory and reimbursement strategy, international market development and launch, sales - management and operations, intellectual property and licensing, fund raising - equity and debt, licensing and intellectual property.
Chief Medical Officer
Dr. Feldman is a founding member of Linshom and has over 25 years clinical experience in respiratory monitoring. He is an associate professor of anesthesiology, SUNY at Buffalo. Dr. Feldman recognized that the ability to monitor respiration outside of a critical care setting was not readily available. That realization led him to seek the expertise of the members of Artep Inc, which resulted in the formation of Linshom Management LLC. The product of that collaboration is Linshom, a respiratory monitor for any person or child with respiratory problems. This monitor has been termed “a game changer” in patient safety and advanced care by unaffiliated parties who have witnessed Linshom.
Dr. Feldman is a founding member of the Linshom team. Since earning a Ph.D. degree in 1965, Dr. Feldman has been actively engaged in theoretical and experimental studies in laboratory settings and in astrophysics. Since 2002 Dr. Feldman has held the position of senior scientist with Artep Inc. Starting in 1972 and until his retirement in 2001 as a senior scientist from the Naval Research Laboratory (NRL) Dr. Feldman participated in studies of data that were acquired by a variety of space instruments as well as by instruments coupled to extremely high power lasers. Dr. Feldman held a two‑year postdoctoral fellowship between 1965 and 1967 at Goddard Space Flight Center and in 1968 he moved to Tel –Aviv Univeristy. In 1969 he was appointed as the first Director of the Wise Astronomical Observatory, where he supervised the construction of the observatory and its early operation. The Observatory includes a 40‑inch stellar telescope and a smaller solar telescope. Dr. Feldman is an author or co‑author of over 430 scientific papers published in refereed journals. He is a member of the International Astronomical Union, and a Fellow of the Optical Society of America and the American Physical Society.
Ashish K.Khanna, MD, FCCP, FCCM, is a staff intensivist & anesthesiologist, Associate Professor of Anesthesiology and Associate Chief for Research with the Department of Anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine, Winston-Salem, NC. Dr.Khanna is the immediate past chair of the Society of Critical Care Medicine’s (SCCM) In-Training Section and a current outgoing chair for the SCCM Postgraduate and Fellowship Education Committee. He is a recent recipient of the SCCM presidential citation for the years 2016, 2017 & 2019 and a successful nominee as a fellow of the American College of Critical Care Medicine (FCCM) in 2018. He is also a part of the SCCM program planning committee (term until 2022), the SCCM Discovery Research Network Steering Committee (term until 2022), the THRIVE ICU survivors task force and the adult item writing committee (term until 2021). As part of the SCCM Anesthesiology section for the last six years, and a current member of the Anesthesiology section Steering Committee and communications sub-committee, he has been extensively involved with the Anesthesiology year-in-review program at SCCM, has presented as faculty, and continues to do the same. Other SCCM faculty presence includes, the conception, design and moderation of the SCCM Critical Care Quiz Show, and Critical Crosstalk sessions, the fellowship program directors’ luncheon and the ‘transitioning to attending’ programs lead by the in-training section. He has authored extensively for Critical Connections – the official newsletter for the society. Dr.Khanna is also vice-chair for the American Society of Anesthesiologists (ASA) committee on critical care medicine and abstract review committee on critical care medicine. He has completed six years with the educational track sub-committee on critical care medicine for the ASA. He is part of the Society of Critical Care Anesthesiologists (SOCCA) committee on education. His research interests include, prediction of post-operative respiratory and cardiac events on the regular nursing floor, outcomes of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. From 2015-2017 Dr.Khanna was the lead investigator for the Angiotensin II in High Output Shock (ATHOS-3) trial, that was subsequently published in the NEJM in the summer of 2017. He also recently lead and completed the Prediction of Opioid Induced Respiratory Depression in Patients Monitored by Capnography (PRODIGY) trial in 16 sites across the world. Earlier this year he was awarded the prestigious Foundation for Anesthesia Education and Research (FAER) mentored research training grant (clinical and translational research) sponsored by the American Society of Anesthesiologists, in the same area of clinical research – prediction of postoperative cardiorespiratory compromise. He is also working on the design and implementation of a novel hypotension prediction score in the ICU, specifically in patients needing emergent endotracheal intubation. Being involved in the big data revolution, Dr.Khanna has partnered with other experts in developing the Artificial Intelligence Diagnosis Engine (AIDE) as part of a successful IBM Watson Artificial Intelligence XPrize effort. This platform will help clinicians generate and document diagnosis specific codes in an effective and efficient manner (www.BRAINXai.com) He has more than 50 peer reviewed papers, two dozen book chapters, editorials, invited non-peer reviewed articles, and online educational videos to his credit and has been invited to talk about his work at prestigious national and international forums.
Dr. Lerman is Clinical Professor of Anesthesia, Women and Children’s Hospital of Buffalo, SUNY at Buffalo and University of Rochester, Rochester, New York. Dr. Lerman completed his anesthesia residency at the University of Toronto in 1982 and a research fellowship in the Cardiovascular Research Institute at UCSF from 1982-1983. Dr. Lerman joined the staff at the Hospital for Sick Children in 1983, was Anaesthetist-inChief at the Hospital for Sick Children from 1991-1996 and was appointed Professor of Anesthesia at the
University of Toronto in 1994. In 2002, he left Toronto and joined the Department of Anesthesia at Women and Children’s Hospital of Buffalo, NY and in 2003 took a part-time position in the Department of Anesthesia at University of Rochester. Dr. Lerman has authored or co-authored more than 110 peer-reviewed manuscripts, more than 160 abstracts, edited two textbooks, published more than 40 review articles, 45 chapters,10 editorials and completed more than 250 visiting professorships in 30 countries. He has been awarded 6 peer‐reviewed grants and more than 25 industry-sponsored grants. He is currently a member of the editorial board of Pediatric Anesthesia and the Journal of Anesthesia (Japan), an Associate Editor of Anesthesia & Analgesia, and a former Editorial Board Member of Anesthesiology.
Dr. Tomer Feldman has been an attending physician at Sentara Rockingham Memorial Hospital (RMH) since 1997 and was the managing partner of Harrisonburg Emergency Physicians from 2003 - 2010. Dr. Feldman is a graduate of Loyola Medical School in Chicago, IL. Tomer completed his residency in Emergency Medicine at Syracuse University Hospital. Dr. Feldman has been a winner of Rockingham Memorial Hospital “Golden Stethoscope” award 2010 for Physician of the Year, was a member of the RMH Foundation board from 2007-2013 and the RMH, long term planning committee from 2008-2010 as well as the Critical Care Committee from 2004-2007, the Radiology Committee from 1998-2002 and the Peer Review (Emergency Department) committee 2013-present. Dr. Feldman is Board Certified in Emergency Medicine and has an active medical license in the State of Virginia and Pennsylvania. Academically, Dr. Feldman is actively involved in providing a comprehensive lecture series in Emergency Medicine to JMU PA students and ED staff. Dr. Feldman recognizes the need for monitoring patients in a variety of settings and has been actively involved with Linshom as a senior consultant.
Mr. Fred Vogt is a Strategic Advisor to Linshom Management LLC. He is President of FKV Enterprises LLC, consulting to senior management. He has been involved in M&A transactions both as a consultant and as a business leader in the corporate world. Mr. Vogt is presently on the Board of Directors of Singulex, Inc., a company with leading edge technology in single molecule counting. He has served in the past as Chairman & CEO and on the Audit and Compensation committees. Prior to forming his consulting business he was Senior Vice President of Specialty Chemicals for Tetra Technologies, Inc. Prior to Tetra, Mr. Vogt worked for Mallinckrodt, Inc. for 26 years holding a variety of ever increasing manufacturing and business responsibilities in pharmaceutical and specialty chemicals culminating as President of Mallinckrodt Baker, Inc., a division of Mallinckrodt focused on laboratory chemicals. Mr. Vogt started his career with Procter & Gamble as an industrial engineer. He holds an MS in Engineering Administration and a BS in Chemical Engineering from University of Missouri Science and Technology.
Mr. John Moser is a founding member of Linshom. He has three decades of experience designing and crafting one-of-a-kind science instruments for space flight. Throughout his career Mr. Moser has excelled at providing solutions to multidisciplinary problems while maintaining the highest levels of reliability for the harshest environments. As an aerospace technologist and engineer he is able to distill complex problems into elegant sensor and instrumentation design. It is his extensive hands-on skill set that Linshom Management LLC tapped to provide an innovative solution for their new monitor. John graduated from Morehead State University, Kentucky with dual majors in Industrial Design and Communications.